Martindale Healthcare

Martindale Pharma is a prominent UK-based specialty pharmaceutical company specializing in the manufacture and distribution of essential medicines. The company is a market leader in opioid addiction treatment and provides a comprehensive portfolio of emergency medicine, critical care, and sterile injectable products. Founded in 1883, Martindale has a long history of supplying both licensed medicines and specials (unlicensed medicines) to the NHS and international markets. In 2017, the company was acquired by the French specialty pharmaceutical group Ethypharm, significantly expanding its European footprint. Martindale operates advanced manufacturing facilities in the UK, focusing on complex formulations and controlled substances.